[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Aretaieion University Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":72},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100620860","comparison-of-the-efficacy-of-continuous-metaraminol-infusion-versus-continuous-norepinephrine-infusion-for-the-prevention-of-hypotension-during-cesarean-section-under-spinal-anaesthesia-a-randomised-controlled-trial-100620860",false,"NCT07363109","Comparison of the Efficacy of Continuous Metaraminol Infusion Versus Continuous Norepinephrine Infusion for the Prevention of Hypotension During Cesarean Section Under Spinal Anaesthesia. A Randomised Controlled Trial.","Prevention of Hypotension During Elective Cesarean Section Under Spinal Anaesthesia With Fixed-rate Metaraminol Infusion Versus Fixed-rate Norepinephrine Infusion: A Double-blind Randomised Controlled Clinical Trial.","Inclusion Criteria:\n\nadult parturients, singleton gestation, elective cesarean section\n\nExclusion Criteria:\n\nASA \\>II, age \\\u003C18 years, Body Mass Index (BMI) \\>40 kg\u002Fm2, body weight \\\u003C50 kg, body weight\\>100 kg, height\\\u003C150 cm, height\\>180 cm, multiple gestation, fetal abnormality, fetal distress, active labor, emergency CT, cardiovascular disease or cerebrovascular disease, pre-existing or pregnancy-induced hypertension, use of antihypertensive medication during pregnancy, preeclampsia, any contraindication for regional anesthesia, such as thrombocytopenia or coagulation disorder, communication or language barriers, lack of informed consent","FEMALE","18 Years","48 Years",{"count":20,"type":21},80,"ESTIMATED","INTERVENTIONAL",[24],"NA","The aim of this double-blind randomised study will be to compare a fixed-rate prophylactic metaraminol infusion to a fixed-rate prophylactic norepinephrine infusion during elective cesarean section under combined spinal-epidural anaesthesia.",[27,28],"Hypotension After Spinal Anesthesia","Hypotension During Cesarean Delivery",[30,31,32,33,34],"metaraminol","norepinephrine","prevention of hypotension","cesarean section","maternal hemodynamics","NOT_YET_RECRUITING","2026-01-15",{"date":38,"type":39},"2026-01-23","ACTUAL",{"date":41,"type":21},"2026-02",{"date":43,"type":21},"2029-03",{"name":45,"class":46},"Aretaieion University Hospital","OTHER",{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},"100544989","chloroprocaine-1-versus-ropivacaine-075-during-cesarean-section-100544989","NCT06376058","Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section","Intrathecal Use of Chloroprocaine 1% and Ropivacaine 0,75% During Elective Cesarean Section. A Comparative Study","annie-mariana","Inclusion Criteria:\n\n* adult parturients, American Society of Anesthesiologists (ASA) I-II,\n* singleton gestation\\>37 weeks\n* elective cesarean section\n\nExclusion Criteria:\n\n* American Society of Anesthesiologists (ASA) \\> III\n* age \\\u003C 18 years\n* singleton gestation \\\u003C37 weeks\n* Body Mass Index (BMI) \\>40 kg\u002Fm2\n* Body weight \\\u003C50 kg\n* Body weight\\>100 kg\n* height\\\u003C150 cm\n* height\\>180 cm\n* multiple gestation\n* emergency delivery\n* fetal abnormality\n* fetal distress\n* pregnancy-induced pathology such as preeclampsia, eclampsia, premature labor, placental abnormalities\n* pregnancy- induced diseases such as hepatic failure, pseudocholinesterase deficiency, neuromuscular diseases\n* lack of informed consent\n* contraindication for regional anesthesia such as thrombocytopenia, coagulation abnormalities, allergy to local anesthetics",{"count":56,"type":21},60,[24],"This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean sections",[60,61],"Cesarean Section","Local Anesthetic","RECRUITING","2025-07-20",{"date":65,"type":39},"2025-07-22",{"date":67,"type":39},"2024-01-10",{"date":69,"type":21},"2026-01-10",{"name":45,"class":46},1,""]